MYC and neoplasm: Moreover, MYC, one of the elevated oncogenic signaling in immunotherapy-resistant ‘cold’ tumors, has been reported to regulate the tumor microenvironment through effects on both innate and adaptive immune effector cells and immune regulatory cytokines [70].